Keywords: spectrum, initiates, ph, ii, satraplatin, trials, pharmaceuticals

Spectrum initiates Ph II satraplatin trials

Article | 19 December 2005

Print This

Spectrum Pharmaceuticals, a California, USA-based specialist drugmaker, says it has has begun accrual for a Phase II study evaluating its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in